Swiss National Bank Regenxbio Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Regenxbio Inc. stock. As of the latest transaction made, Swiss National Bank holds 81,500 shares of RGNX stock, worth $589,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,500

Previous 81,500 -0.0%

Holding current value

$589,245

Previous $953,000 10.39%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$12.17 - $24.61 $42,595 - $86,135	3,500 Added 4.49%	81,500 $1.72 Million
Q4 2023 Feb 06, 2024	SELL	$12.89 - $20.82 $103,120 - $166,560	-8,000 Reduced 9.3%	78,000 $1.4 Million
Q3 2023 Nov 08, 2023	BUY	$16.46 - $19.99 $90,530 - $109,944	5,500 Added 6.83%	86,000 $1.42 Million
Q2 2023 Aug 09, 2023	BUY	$17.23 - $21.71 $18,953 - $23,881	1,100 Added 1.39%	80,500 $1.61 Million
Q1 2023 May 10, 2023	SELL	$18.08 - $24.55 $168,143 - $228,315	-9,300 Reduced 10.48%	79,400 $1.5 Million
Q4 2022 Feb 08, 2023	BUY	$20.4 - $24.73 $36,720 - $44,514	1,800 Added 2.07%	88,700 $2.01 Million
Q3 2022 Nov 09, 2022	BUY	$22.29 - $35.04 $28,977 - $45,552	1,300 Added 1.52%	86,900 $2.3 Million
Q2 2022 Aug 09, 2022	BUY	$19.35 - $35.04 $187,695 - $339,888	9,700 Added 12.78%	85,600 $2.11 Million
Q1 2022 May 09, 2022	BUY	$24.62 - $34.31 $132,948 - $185,274	5,400 Added 7.66%	75,900 $2.52 Million
Q3 2021 Nov 08, 2021	BUY	$29.09 - $45.68 $17,454 - $27,408	600 Added 0.86%	70,500 $2.96 Million
Q2 2021 Aug 06, 2021	SELL	$32.46 - $40.48 $512,868 - $639,584	-15,800 Reduced 18.44%	69,900 $2.72 Million
Q1 2021 May 07, 2021	BUY	$33.61 - $49.95 $470,540 - $699,300	14,000 Added 19.53%	85,700 $2.92 Million
Q3 2020 Nov 09, 2020	BUY	$27.01 - $40.26 $32,412 - $48,312	1,200 Added 1.7%	71,700 $1.97 Million
Q2 2020 Aug 05, 2020	BUY	$27.75 - $43.44 $169,275 - $264,984	6,100 Added 9.47%	70,500 $2.6 Million
Q1 2020 May 08, 2020	BUY	$21.5 - $54.2 $21,500 - $54,200	1,000 Added 1.58%	64,400 $2.09 Million
Q4 2019 Feb 06, 2020	BUY	$34.54 - $44.87 $55,264 - $71,792	1,600 Added 2.59%	63,400 $2.6 Million
Q3 2019 Nov 12, 2019	BUY	$31.84 - $50.88 $28,656 - $45,792	900 Added 1.48%	61,800 $2.2 Million
Q2 2019 Aug 02, 2019	BUY	$42.0 - $59.29 $88,200 - $124,509	2,100 Added 3.57%	60,900 $3.13 Million
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $126,542 - $193,595	3,100 Added 5.57%	58,800 $3.37 Million
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $219,016 - $420,840	5,600 Added 11.18%	55,700 $2.34 Million
Q3 2018 Nov 08, 2018	BUY	$65.0 - $82.15 $84,500 - $106,795	1,300 Added 2.66%	50,100 $3.78 Million
Q2 2018 Aug 09, 2018	BUY	$27.2 - $74.35 $78,880 - $215,614	2,900 Added 6.32%	48,800 $3.5 Million
Q1 2018 May 04, 2018	BUY	$24.05 - $37.5 $79,365 - $123,750	3,300 Added 7.75%	45,900 $1.37 Million
Q3 2017 Nov 03, 2017	BUY	$18.0 - $32.95 $766,800 - $1.4 Million	42,600	42,600 $1.4 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $313M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Regenxbio Inc. Transaction History